Corex opens new clinical trial logistics hub in Ukraine

By Maggie Lynch

- Last updated on GMT

(Image: Getty/Naruedom)
(Image: Getty/Naruedom)

Related tags Clinical trial Clinical data management Supply chain Logistics Clinical trial protocol

Corex will expand to additional markets after opening a new clinical trial logistics hub in Ukraine.

The new strategic Kyiv, Ukraine-based location comes after Corex experienced operational growth as a clinical trials logistics company in the country. The opening of this center, according to Corex, reinforces its commitment to the region’s growing clinical trial market.

“We are convinced that this latest addition to Corex international infrastructure will serve as a stepping stone to both strengthening the existing operations and opening new markets in the coming months,”​ said Rostislav Kachan, head of Corex Ukraine in a statement.

The logistics hub features temperature-controlled storage capabilities and walk-in refrigerators and has been inspected by the Ukrainian State Administration on Medicinal products.

Kachan said the company has “hit the ground running” ​and is already started managing existing clients at its new facility.

Expanding footprint in expanding region

In 2014, Synergy Research Group revealed that 108 of the 155 trials approved​ in Ukraine in the first half of 2014 were multinational, multi-center clinical trials. At the time, the contract research organizations (CROs) Quintiles (now Iqvia), PPD, and PSI AG conducted a majority of these trials.

Ukraine has an approximate population of 45m and follows EU directives and guidelines for clinical trial legislation and data quality. The company stated that clinical trial data from Ukraine is corroborated by both US Food and Drug Administration (FDA) and European Medicines Agency (EMA) inspections.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more